首页> 美国卫生研究院文献>Journal of Pain Research >No evidence of real progress in treatment of acute pain 1993–2012: scientometric analysis
【2h】

No evidence of real progress in treatment of acute pain 1993–2012: scientometric analysis

机译:没有证据表明急性疼痛治疗的真正进展1993-2012年:科学计量分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Over the past 2 decades, many new techniques and drugs for the treatment of acute pain have achieved widespread use. The main aim of this study was to assess the progress in their implementation using scientometric analysis. The following scientometric indices were used: 1) popularity index, representing the share of articles on a specific technique (or a drug) relative to all articles in the field of acute pain; 2) index of change, representing the degree of growth in publications on a topic compared to the previous period; and 3) index of expectations, representing the ratio of the number of articles on a topic in the top 20 journals relative to the number of articles in all (>5,000) biomedical journals covered by PubMed. Publications on specific topics (ten techniques and 21 drugs) were assessed during four time periods (1993–1997, 1998–2002, 2003–2007, and 2008–2012). In addition, to determine whether the status of routine acute pain management has improved over the past 20 years, we analyzed surveys designed to be representative of the national population that reflected direct responses of patients reporting pain scores. By the 2008–2012 period, popularity index had reached a substantial level (≥5%) only with techniques or drugs that were introduced 30–50 years ago or more (epidural analgesia, patient-controlled analgesia, nerve blocks, epidural analgesia for labor or delivery, bupivacaine, and acetaminophen). In 2008–2012, promising (although modest) changes of index of change and index of expectations were found only with dexamethasone. Six national surveys conducted for the past 20 years demonstrated an unacceptably high percentage of patients experiencing moderate or severe pain with not even a trend toward outcome improvement. Thus, techniques or drugs that were introduced and achieved widespread use for acute pain management within the past 20 years have produced no changes in scientometric indices that would indicate real progress and have failed to improve national outcomes for relief of acute pain. Two possible reasons for this are discussed: 1) the difference between the effectiveness of old and new techniques is not clinically meaningful; and 2) resources necessary for appropriate use of new techniques in routine pain management are not adequate.
机译:在过去的20年中,用于治疗急性疼痛的许多新技术和药物已得到广泛使用。这项研究的主要目的是使用科学计量分析来评估其实施的进展。使用了以下科学计量学指标:1)人气指数,代表特定技术(或药物)上的文章相对于急性疼痛领域中所有文章的份额; 2)变化指数,代表与上一时期相比某个主题的出版物的增长程度; 3)期望指数,代表前20种期刊中某个主题的文章数与PubMed涵盖的所有(> 5,000种)生物医学期刊中的文章数之比。在四个时期(1993-1997年,1998-2002年,2003-2007年和2008-2012年)评估了有关特定主题(十种技术和21种药物)的出版物。此外,为了确定过去20年来常规急性疼痛管理的状况是否有所改善,我们分析了旨在代表全国人口的调查,这些调查反映了报告疼痛评分的患者的直接反应。到2008-2012年期间,仅在30到50年前或更早引进的技术或药物(硬膜外镇痛,患者自控镇痛,神经阻滞,硬膜外分娩镇痛)的普及指数才达到实质性水平(≥5%)或布比卡因和对乙酰氨基酚)。在2008-2012年,仅地塞米松发现了变化指数和期望指数的有希望的(尽管是适度的)变化。在过去的20年中进行的六次全国性调查显示,遭受中度或重度疼痛的患者比例过高,甚至没有改善结果的趋势。因此,在过去的20年中被引入并在急性疼痛管理中得到广泛使用的技术或药物,其科学计量指标没有任何变化,表明实际的进展,并且未能改善缓解急性疼痛的国家成果。讨论了两个可能的原因:1)新技术和新技术的有效性之间的差异在临床上没有意义。 2)在日常疼痛管理中适当使用新技术所需的资源不足。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号